ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Gentiopicroside promotes the osteogenesis of bone mesenchymal stem cells by modulation of β-catenin-BMP2 signalling pathway

Jiang, Huaji; Zhong, Jialiang; Li, Wenjun; Dong, Jianghui; Xian, Cory J.; Shen, Yung-Kang; Yao, Lufeng; Wu, Qiang*; Wang, Liping*南方医科大学; 汕头大学; 中山大学; 6
Journal of Cellular and Molecular Medicine2021-12DOI: 10.1111/jcmm.16410
7被引16阅读
引用收藏
分享

摘要

Osteoporosis is characterized by increased bone fragility, and the drugs used at present to treat osteoporosis can cause adverse reactions. Gentiopicroside (GEN), a class of natural compounds with numerous biological activities such as anti-resorptive properties and protective effects against bone loss. Therefore, the aim of this work was to explore the effect of GEN on bone mesenchymal stem cells (BMSCs) osteogenesis for a potential osteoporosis therapy. In vitro, BMSCs were exposed to GEN at different doses for 2 weeks, whereas in vivo, ovariectomized osteoporosis was established in mice and the therapeutic effect of GEN was evaluated for 3 months. Our results in vitro showed that GEN promoted the activity of alkaline phosphatase, increased the calcified nodules in BMSCs and up-regulated the osteogenic factors (Runx2, OSX, OCN, OPN and BMP2). In vivo, GEN promoted the expression of Runx2, OCN and BMP2, increased the level of osteogenic parameters, and accelerated the osteogenesis of BMSCs by activating the BMP pathway and Wnt/beta-catenin pathway, effect that was inhibited using the BMP inhibitor Noggin and Wnt/beta-catenin inhibitor DKK1. Silencing the beta-catenin gene and BMP2 gene blocked the osteogenic differentiation induced by GEN in BMSCs. This block was also observed when only beta-catenin was silenced, although the knockout of BMP2 did not affect beta-catenin expression induced by GEN. Therefore, GEN promotes BMSC osteogenesis by regulating beta-catenin-BMP signalling, providing a novel strategy in the treatment of osteoporosis.

学科与关键词

关键词
BMP pathwayGentiopicrosideosteogenic factorsosteogenic parametersosteoporosisWnt/beta-catenin pathway
相关
加载中…
  • Myricitrin promotes osteogenesis and prevents ovariectomy bone mass loss via the PI3K/AKT signalling pathway
    Li, Jianliang; Mai, Jiale; Zhang, Meng; Ma, Yanhuai; He, Qi; Gong, Dawei; Xiao, Jiacong; Li, Miao; Chen, Weijian; Li, Zhen; Chen, Shuai; Pan, Zhaofeng; Li, Shaocong; Wang, Haibin*Journal of Cellular Biochemistry, 2023, 124(8): 1155-1172.
  • Network pharmacology identifies fisetin as a treatment for osteoporosis that activates the Wnt/β-catenin signaling pathway in BMSCs
    Liang, Guihong; Zhao, Jinlong; Pan, Jianke; Yang, Yuan; Dou, Yaoxing; Yang, Weiyi; Zeng, Lingfeng*; Liu, Jun*Journal of Orthopaedic Surgery and Research, 2023, 18(1): 312.被引 1
  • Ginsenoside Compound K Enhances Fracture Healing via Promoting Osteogenesis and Angiogenesis
    Ding, Lingli; Gu, Song; Zhou, Bingyu; Wang, Min; Zhang, Yage; Wu, Siluo; Zou, Hong; Zhao, Guoping; Gao, Zhao*; Xu, Liangliang*Frontiers in Pharmacology, 2022, 13: 855393.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Cellular and Molecular Medicine
发表日期
2021-12
卷期
第 25 卷, 第 23 期
页码
10825-10836
DOI
10.1111/jcmm.16410
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Australia National Health and Medical Research Council (NHMRC) [1158402]; National Natural Science Foundation of China (NSFC) [81671928]; Ningbo Science &Technology Program [202003N4243]; Zhejiang Medical Science &Technology Program [2021KY329]

作者

  • J

    Jiang, Huaji (第一作者)

    shantou univ · southern med univ

  • Z

    Zhong, Jialiang

    sun yat sen univ

查看全部 9 位作者收起作者
  • L

    Li, Wenjun

    shantou univ

  • D

    Dong, Jianghui

  • X

    Xian, Cory J.

  • S

    Shen, Yung-Kang

  • Y

    Yao, Lufeng

    6

  • W

    Wu, Qiang (通讯)

    shantou univ

  • W

    Wang, Liping (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417